Eloxx Pharmaceuticals, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q3 2023

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Eloxx Pharmaceuticals, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2023.
  • Eloxx Pharmaceuticals, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2023 was 2.75M shares, a 26.8% increase year-over-year.
  • Eloxx Pharmaceuticals, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 2.17M shares, a 23.9% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2023 2.75M +581K +26.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-13
Q2 2023 2.21M +46K +2.12% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-11
Q1 2023 2.17M +81 +0% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-12
Q4 2022 2.17M Oct 1, 2022 Dec 31, 2022 10-K 2023-03-31
Q3 2022 2.17M -84M -97.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-13
Q2 2022 2.17M -64.2M -96.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 2.17M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-12
Q3 2021 86.2M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 66.4M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.